Processing

Please wait...

Settings

Settings

1. WO2008098211 - TREATMENT OF GLAUCOMA AND DIABETIC RETINOPATHY WITH MORINDA CITRIFOLIA ENHANCED FORMULATIONS

Publication Number WO/2008/098211
Publication Date 14.08.2008
International Application No. PCT/US2008/053487
International Filing Date 08.02.2008
Chapter 2 Demand Filed 08.12.2008
IPC
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18
Magnoliophyta (angiosperms)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3
Drugs for disorders of the metabolism
08
for glucose homeostasis
10
for hyperglycaemia, e.g. antidiabetics
A61K 36/18 (2006.01)
A61P 3/10 (2006.01)
CPC
A61K 36/18
Applicants
  • TAHITIAN NONI INTERNATIONAL, INC. [US/US]; 333 West River Park Drive Provo, UT 84604, US (AllExceptUS)
  • PALU, Afa, K. [TO/US]; US (UsOnly)
  • JENSEN, Jarakae [US/US]; US (UsOnly)
  • WEST, Brett, J. [US/US]; US (UsOnly)
  • STORY, Stephen [US/US]; US (UsOnly)
Inventors
  • PALU, Afa, K.; US
  • JENSEN, Jarakae; US
  • WEST, Brett, J.; US
  • STORY, Stephen; US
Agents
  • MARROTT, Jarod, R.; Kirton & Mcconkie 1800 Eagle Gate Tower 60 East South Temple Salt Lake City, UT 84111, US
Priority Data
12/027,92007.02.2008US
60/888,86808.02.2007US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) TREATMENT OF GLAUCOMA AND DIABETIC RETINOPATHY WITH MORINDA CITRIFOLIA ENHANCED FORMULATIONS
(FR) TRAITEMENT DU GLAUCOME ET DE LA RÉTINOPATHIE DIABÉTIQUE AVEC DES FORMULATIONS AMÉLIORÉES AVEC DU MORINDA CITRIFOLIA
Abstract
(EN)
The present invention relates to methods and formulations directed inhibiting carbonic anhydrase, fatty acid amide hydrolase and endothelin-converting enzymes comprising the administration of processed Monnda citrifolia based formulations.
(FR)
L'invention concerne des procédés et des formulations inhibant l'anhydrase carbonique, l'hydrolase d'amide d'acide gras et des enzymes convertissant l'endothéline comprenant l'administration de formulations à base de Morinda citrifolia traitées.
Latest bibliographic data on file with the International Bureau